IL94566A0 - Monoclonal antibodies for inducing tolerance to an antigen - Google Patents

Monoclonal antibodies for inducing tolerance to an antigen

Info

Publication number
IL94566A0
IL94566A0 IL94566A IL9456690A IL94566A0 IL 94566 A0 IL94566 A0 IL 94566A0 IL 94566 A IL94566 A IL 94566A IL 9456690 A IL9456690 A IL 9456690A IL 94566 A0 IL94566 A0 IL 94566A0
Authority
IL
Israel
Prior art keywords
antigen
monoclonal antibodies
depleting
inducing tolerance
monoclonal antibody
Prior art date
Application number
IL94566A
Other languages
English (en)
Original Assignee
Cobbold Stephen P
Waldmann Herman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cobbold Stephen P, Waldmann Herman filed Critical Cobbold Stephen P
Publication of IL94566A0 publication Critical patent/IL94566A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2815—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2812—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A61K2039/507—Comprising a combination of two or more separate antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL94566A 1989-05-31 1990-05-31 Monoclonal antibodies for inducing tolerance to an antigen IL94566A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898912497A GB8912497D0 (en) 1989-05-31 1989-05-31 Monoclonal antibodies

Publications (1)

Publication Number Publication Date
IL94566A0 true IL94566A0 (en) 1991-03-10

Family

ID=10657649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL94566A IL94566A0 (en) 1989-05-31 1990-05-31 Monoclonal antibodies for inducing tolerance to an antigen

Country Status (19)

Country Link
EP (1) EP0474691B1 (de)
JP (1) JP2763197B2 (de)
KR (1) KR0183029B1 (de)
AT (1) ATE145246T1 (de)
AU (1) AU657255B2 (de)
CA (1) CA2055615C (de)
DD (1) DD296843A5 (de)
DE (1) DE69029134T2 (de)
DK (1) DK0474691T3 (de)
ES (1) ES2096588T3 (de)
GB (1) GB8912497D0 (de)
HU (1) HUT61341A (de)
IE (1) IE80735B1 (de)
IL (1) IL94566A0 (de)
MY (1) MY135673A (de)
NZ (1) NZ233889A (de)
PT (1) PT94214B (de)
WO (1) WO1990015152A1 (de)
ZA (1) ZA904174B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9100741D0 (en) * 1991-01-14 1991-02-27 Univ London Treatment of disease
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
CA2140933A1 (en) * 1992-08-21 1994-02-22 Paula M. Jardieu Method for treating an lfa-1 mediated disorder
US6270766B1 (en) 1992-10-08 2001-08-07 The Kennedy Institute Of Rheumatology Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
EP0840618B1 (de) * 1995-05-18 2003-04-23 Ortho-McNeil Pharmaceutical, Inc. Induktion von immunologischer toleranz unter verwendung von nicht-zellmengeverringernden anti-cd4-antikoepern
NZ517202A (en) 1999-08-24 2004-05-28 Medarex Inc Human CTLA-4 antibodies and their uses
US7011952B2 (en) 2000-02-22 2006-03-14 University Of Iowa Research Foundation Diagnostics and therapeutics for macular degeneration-related disorders
DK1287364T3 (da) 2000-04-29 2009-03-02 Univ Iowa Res Found Diagnostisk og terapi til makulære degenerationsrelaterede lidelser
DE60238533D1 (de) * 2001-06-14 2011-01-20 Cambridge Entpr Ltd Nicht-depletierender Antikörper TRX-1 gegen CD4 und dessen Verwendungen
US7541443B2 (en) 2001-06-14 2009-06-02 Tolerrx, Inc. Anti-CD4 antibodies
EP1460088A1 (de) 2003-03-21 2004-09-22 Biotest AG Humanisierter Antikörper gegen CD4 mit immunsuppressiven Merkmalen
GB0314461D0 (en) * 2003-06-20 2003-07-23 Isis Innovation Suppression of transplant rejection
RU2007102055A (ru) * 2004-06-22 2008-07-27 Толерркс, Инк. (Us) Оптимизированное введение доз анти-cd4-антител для индукции толерантности у приматов
EP2262838B1 (de) 2008-03-13 2016-04-13 Biotest AG Mittel zur behandlung einer erkrankung
MX2010010027A (es) 2008-03-13 2011-05-02 Biotest Ag Agente para tratar enfermedad.
RU2539110C2 (ru) 2008-03-13 2015-01-10 Биотест Аг Способ лечения аутоиммунного заболевания (варианты)
WO2009149382A2 (en) * 2008-06-06 2009-12-10 Baylor Research Institute Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
AR077718A1 (es) * 2008-07-15 2011-09-21 Genentech Inc Metodos para tratar enfermedades autoinmunes usando anticuerpos anti cd4. formulacion farmaceutica
GB0920944D0 (en) 2009-11-30 2010-01-13 Biotest Ag Agents for treating disease
WO2024112867A1 (en) 2022-11-23 2024-05-30 University Of Georgia Research Foundation, Inc. Compositions and methods of use thereof for increasing immune responses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608068D0 (en) * 1986-04-02 1986-05-08 Cobbold S P Monoclonal antibodies

Also Published As

Publication number Publication date
DE69029134T2 (de) 1997-03-06
HUT61341A (en) 1992-12-28
ATE145246T1 (de) 1996-11-15
EP0474691A1 (de) 1992-03-18
EP0474691B1 (de) 1996-11-13
PT94214A (pt) 1991-02-08
AU5725890A (en) 1991-01-07
AU657255B2 (en) 1995-03-09
JPH04505919A (ja) 1992-10-15
KR0183029B1 (ko) 1999-04-01
CA2055615A1 (en) 1990-12-13
PT94214B (pt) 1997-03-31
HU905134D0 (en) 1992-02-28
DD296843A5 (de) 1991-12-19
WO1990015152A1 (en) 1990-12-13
CA2055615C (en) 2001-07-17
IE80735B1 (en) 1998-12-30
GB8912497D0 (en) 1989-07-19
DK0474691T3 (da) 1996-12-02
MY135673A (en) 2008-06-30
NZ233889A (en) 1997-06-24
ZA904174B (en) 1992-02-26
JP2763197B2 (ja) 1998-06-11
DE69029134D1 (de) 1996-12-19
IE901949L (en) 1990-11-30
ES2096588T3 (es) 1997-03-16

Similar Documents

Publication Publication Date Title
ZA904174B (en) Monoclonal antibodies for inducing tolerance
IL93840A0 (en) Novel monoclonal antibody to novel antigen associated with human tumors
EP0285059A3 (en) Monoclonal antibodies against glycolipid antigens and their use
ES2124533T3 (es) Anticuerpos monoclonales inmunoestimulantes.
ZA887771B (en) Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
IL74156A (en) Method for the preparation of a monoclonal antibody and of an immortalized cell producing the same and pharmaceutical compositions containing the monoclonal antibody
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
EP0444856A3 (en) Diagnostic assay for alzheimer's disease
GR3029774T3 (en) Method of preparing a radioactive rhenium complex solution.
MY107079A (en) Method of reducing immunoglobulin e responses
JPS5516290A (en) Purified antigen for testing against neisseria gonorrhoeae antibody
AU608413B2 (en) Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
EP0460607A3 (en) Novel monoclonal antibody to novel antigen associated with human tumors
EP0153871A3 (de) Steigerung der Antigenimmunogenität mittels Antikörper
MY107386A (en) Method of preventing or reducing eosinophilia
EP0585364A4 (de) Das durch den monoklonalen menschlichen antikörper 81av78 erkannte antigen ctaa 81av78.
EP0320866A3 (de) Schützendes immundominantes Epitop in der S1-Untereinheit von Pertussistoxin
CA2054689A1 (en) An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
EP0537168A4 (en) Ctaa 28a32, the antigen recognized by mca 28a32
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
EP0334076A3 (en) Monoclonal antibody capable of recognizing an antigen associated with human arteriosclerosis, and process for preparing the same
DE69322960D1 (de) Empfängnisverhütender impfstoff
IT1254570B (it) Antigeni legati alla superfice esterna di eritrociti e procedimento per la loro preparazione.
GB1155683A (en) New Polyvalent Immunizing Agents and Methods for their Production